Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy
about
c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemiaDifferential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.Separase: Function Beyond Cohesion Cleavage and an Emerging Oncogene.Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.Kinase-templated abiotic reaction.Increased separase activity and occurrence of centrosome aberrations concur with transformation of MDS.
P2860
Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clonal Evolution and Blast Cri ...... ype CML under Imatinib Therapy
@ast
Clonal Evolution and Blast Cri ...... ype CML under Imatinib Therapy
@en
type
label
Clonal Evolution and Blast Cri ...... ype CML under Imatinib Therapy
@ast
Clonal Evolution and Blast Cri ...... ype CML under Imatinib Therapy
@en
prefLabel
Clonal Evolution and Blast Cri ...... ype CML under Imatinib Therapy
@ast
Clonal Evolution and Blast Cri ...... ype CML under Imatinib Therapy
@en
P2093
P2860
P50
P1433
P1476
Clonal Evolution and Blast Cri ...... ype CML under Imatinib Therapy
@en
P2093
Christel Weiß
German CML Study Group
Helga Kleiner
Martin C Müller
Rüdiger Hehlmann
Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung
Wiltrud Haaß
Wolf-Karsten Hofmann
Wolfgang Seifarth
P2860
P304
P356
10.1371/JOURNAL.PONE.0129648
P407
P577
2015-06-18T00:00:00Z